A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver. This disease, known as metastatic uveal melanoma, is traditionally very hard to treat and usually has poor outcomes...
4336 Plainfield Ave ne Grand Rapids Michigan 49525
16162083711
fitlifehere@gmail.com
Copyright © 2023 fitlife. All Rights Reserved